Letters to the Editor
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: February 4, 2025
Accepted: February 9, 2025
Accepted: February 9, 2025
801
Views
768
Downloads
48
HTML
Authors
A case of Acute graft-versus-host disease (aGVHD) with severe cutaneous manifestations resembling Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) is presented.
Downloads
Download data is not yet available.
Citations
How to Cite
“Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025020. doi:10.4084/MJHID.2025.020.
Copyright (c) 2025 Fahir Ozturk, Mehmet Sezgin Pepeler, Esra Ucaryilmaz Ozhamam, Gulten Korkmaz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
